Money for Italian biotech

A group of biotech entrepreneurs, led by a former executive at Novartis, has announced plans to raise €50 million for a fund that will invest in Italian life science. The fund is being managed by AurorA-TT, a technology transfer company set up in Milan earlier this year.

Full text available to subscribers only. Click here for information on subscribing to MedNous.